BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 98 filers reported holding BIOSCRIP INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $18,690,000 | +30.0% | 7,188,615 | 0.0% | 1.39% | +56.6% |
| Q1 2019 | $14,377,000 | -44.0% | 7,188,615 | 0.0% | 0.89% | -45.9% |
| Q4 2018 | $25,663,000 | +15.2% | 7,188,615 | 0.0% | 1.64% | +44.3% |
| Q3 2018 | $22,285,000 | +5.8% | 7,188,615 | 0.0% | 1.14% | +53.0% |
| Q2 2018 | $21,063,000 | +19.1% | 7,188,615 | 0.0% | 0.74% | +32.1% |
| Q1 2018 | $17,684,000 | -4.5% | 7,188,615 | +13.0% | 0.56% | -4.6% |
| Q4 2017 | $18,511,000 | +5.8% | 6,361,250 | 0.0% | 0.59% | -0.5% |
| Q3 2017 | $17,493,000 | +32294.4% | 6,361,250 | +31706.2% | 0.59% | +59200.0% |
| Q2 2017 | $54,000 | +350.0% | 20,000 | +69.5% | 0.00% | 0.0% |
| Q4 2016 | $12,000 | – | 11,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RIVULET CAPITAL, LLC | 1,400,000 | $11,676,000 | 9.66% |
| DSC Advisors, L.P. | 3,150,000 | $26,272,000 | 7.40% |
| Consonance Capital Management LP | 3,950,839 | $32,950,000 | 4.90% |
| NFC Investments, LLC | 951,580 | $7,936,000 | 3.88% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,090,789 | $17,437,000 | 3.07% |
| KEANE CAPITAL MANAGEMENT INC | 310,000 | $2,585,000 | 2.41% |
| First Washington CORP | 454,200 | $3,788,000 | 2.12% |
| GLENHILL ADVISORS LLC | 2,486,490 | $20,737,000 | 1.68% |
| ARDSLEY ADVISORY PARTNERS LP | 1,500,000 | $12,510,000 | 1.60% |
| True Bearing Asset Management LP | 357,161 | $2,979,000 | 1.55% |